إعلان
إعلان
IRD
I
Opus Genetics, Inc. Common Stock
1.94
USDبرعاية
-0.06
-3.25%
٠٩ يناير, ١٥:٣٢ UTC -5
مغلق
بعد الإغلاق
1.94
0.00
0.00%
تقارير أرباح IRD
النسبة الإيجابية المفاجئة
IRD تفوق 25 من 36 آخر التقديرات.
69%
التقرير التالي
بيانات التقرير القادم
٣٠ مارس ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$3.31M
/-$0.12
التغير الضمني من Q3 25 (Revenue/ EPS)
+7.53%
/-52.00%
التغير الضمني من Q4 24 (Revenue/ EPS)
-23.04%
/-45.45%
Opus Genetics, Inc. Common Stock earnings per share and revenue
On ١٢ نوفمبر ٢٠٢٥, IRD reported earnings of -0.25 USD per share (EPS) for Q3 25, missing the estimate of -0.13 USD, resulting in a -90.40% surprise. Revenue reached 3.08 مليون, compared to an expected 3.11 مليون, with a -0.87% difference. The market reacted with a -2.54% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 المحللين forecast an EPS of -0.12 USD, with revenue projected to reach 3.31 مليون USD, implying an نقصان of -52.00% EPS, and زيادة of 7.53% in Revenue from the last quarter.
الأسئلة الشائعة
What were Opus Genetics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Opus Genetics, Inc. Common Stock reported EPS of -$0.25, missing estimates by -90.4%, and revenue of $3.08M, -0.87% below expectations.
How did the market react to Opus Genetics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.54%, changed from $1.97 before the earnings release to $1.92 the day after.
When is Opus Genetics, Inc. Common Stock expected to report next?
The next earning report is scheduled for ٣٠ مارس ٢٠٢٦.
What are the forecasts for Opus Genetics, Inc. Common Stock's next earnings report?
Based on 10
المحللين, Opus Genetics, Inc. Common Stock is expected to report EPS of -$0.12 and revenue of $3.31M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان